Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe
Main Authors: | Deger, Melike, Eisterer, Wolfgang, Kutikova, Lucie, Salek, Sam |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer-Verlag
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538022/ |
Similar Items
-
Flexible dosing with Darbepoetin alfa for the treatment of chemotherapy-induced anemia
by: Wauters, Isabelle, et al.
Published: (2006) -
Switch from epoetin to darbepoetin alfa in hemodialysis: dose equivalence and hemoglobin stability
by: Arrieta, Javier, et al.
Published: (2014) -
Extended dosing of darbepoetin alfa in peritoneal dialysis patients
by: Feriani, Mariano, et al.
Published: (2011) -
Darbepoetin alpha in the treatment of cancer chemotherapy-induced anemia
by: Grossi, Alberto, et al.
Published: (2007) -
Darbepoetin Versus Epoetin Alfa for the Correction of Anemia in Cancer Patients Receiving Radiotherapy or Chemoradiotherapy Treatment
by: Ots, Pilar Ma Samper, et al.
Published: (2008)